Promaxo is thrilled to be exhibiting at Arab Health 2024, the second-largest healthcare conference in the world. In attendance from the Promaxo leadership team will be Amit Vohra, CEO, Srirama Venkataraman, CIO, and Prithipal Sethi, CMO. We will share our latest advancements in transforming prostate patient care with our in-office MRI. Visit us at booth S1. J54, or set up a time to meet here at https://bit.ly/3O9EOGQ.
The American Urological Association (AUA) continues to be a leader in developing innovative, evidence-based quality education for urologists and urologic health care professionals worldwide. Through the Annual Meeting—and other year-round educational offerings—the AUA sets the highest standards for urologic education.
The purpose of SRS is the dissemination of scientific activities, educational/training activities and research in robotic surgery, the organization and implementation of scientific meetings and presentations, as well as the recognition of excellence in the area of robotic surgery.
This is the premier radiation oncology scientific event in the world.
The Southeastern Section of the AUA (SESAUA) is but one of the many "Sections" of the American Urological Association, Inc., the "AUA." The AUA itself is now an international organization of urologists, numbering more than 13,000. The Southeastern Section is composed of almost 2,100 urologists; all the active members having been certified by the American Board of Urology, practicing, teaching, and researching in 9 of the southeastern United States, Panama, Puerto Rico, and the U.S. Virgin Islands. Numerically, this is the largest of all the sections of the AUA. This Section continues to grow and contribute to the body of scientific knowledge in Urology, as does the entire AUA. The American Urological Association, and each of its component Sections, is dedicated to the "study, diagnosis, and treatment of diseases of the genitourinary tract" in adult and pediatric patients.
From world-class science to patient-centered care, the 2023 ASCO Genitourinary (GU) Cancers Symposium offers new, innovative findings in the study, diagnosis, and treatment of GU malignancies.
The Mountain Outdoor GU Lecture Series Conference is intended for physicians, residents, advanced practice providers and others interested in urologic care. The most up to date and practical information on delivering urologic care will be presented in an inclusive and interactive format through lectures, debates, and discussions. A wide variety of clinically relevant topics from the latest in urologic oncology to challenging cases in neurogenic bladder, and pediatric practice have been included to appeal to a broad range of interests. This conference will provide a collaborative forum for urologic care leaders to share the profession’s evidence-based practice, innovative ideas, and share methods that can be used to improve patient outcomes and drive value-based care.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and North American Robotic Urology Symposium (NARUS). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
With constant changes in urology, it is imperative that the practicing urologist remains on the cutting edge. For this reason, the first Jackson Hole Urological Conference began thirty nine years ago. The format of the meeting focuses on balancing the urologist’s intellectual stimulation (applicable to his/her practice) with the input from our board and many renowned faculty members.
The International Prostate Cancer Update (IPCU), is a multi-day, CME-accredited conference focused on new developments in prostate cancer treatment, diagnosis, and prevention. IPCU 33 will feature lectures, interactive discussions, panel roundtables, debates, and case reports. This conference is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer.
